Company news

Teleflex Incorporated news in 2025

Teleflex Incorporated's news releases, calls and decks from 2025, newest first.

View company

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

December 9, 2025

Teleflex to Present at the Jefferies Global Healthcare Conference in London

November 14, 2025

Teleflex Announces Quarterly Dividend

November 6, 2025

Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook

November 6, 2025

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

October 16, 2025

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

September 11, 2025

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 26, 2025

Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy

August 19, 2025

Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook

July 31, 2025

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

July 17, 2025

Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business

July 1, 2025

New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

June 12, 2025

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

June 11, 2025

Teleflex Publishes 2024 Global Impact Report

May 19, 2025

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting

May 15, 2025

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy

May 13, 2025

Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook

May 1, 2025

Teleflex to Present at the BofA Securities 2025 Health Care Conference

April 30, 2025

Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device

April 30, 2025

Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting

April 24, 2025

Teleflex Announces First Quarter 2025 Earnings Conference Call Information

April 17, 2025

Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP)

April 1, 2025

Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference

March 27, 2025

Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress

March 25, 2025

Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results

February 27, 2025

Teleflex Announces Planned Retirement of Thomas Powell As Chief Financial Officer

February 27, 2025

Teleflex Announces Intent to Separate into Two Publicly Traded Companies

February 27, 2025

Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business

February 27, 2025

Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference

February 18, 2025

Calls in 2025

Decks in 2025